- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04755790
To Assess the Utility of the Point Digit in a Clinical Take-home Study
December 28, 2023 updated by: Point Designs
This study will allow us to assess whether the Point Digit confers functional and psychological benefit to persons with partial hand amputations in an unconstrained environment.
The use of the Point Digit outside of the laboratory will allow for a wider variety of uses and for a more realistic simulation of the product being used in the field.
This well-controlled trial (without randomization of subjects) will produce the first Level II-1 medical evidence in our field of partial hand prosthetic design as described by the 1989 U.S. Preventive Services Task Force.
Furthermore, this study will provide important data to support providers who are requesting reimbursement from payers.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
13
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Colorado
-
Lafayette, Colorado, United States, 80026
- Point Designs
-
-
Kansas
-
Overland Park, Kansas, United States, 66209
- Arm Dynamics
-
-
Minnesota
-
Maple Grove, Minnesota, United States, 55369
- Arm Dynamics
-
-
Oregon
-
Portland, Oregon, United States, 97223
- Arm Dynamics
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19146
- Arm Dynamics
-
-
Texas
-
Houston, Texas, United States, 77004
- Arm Dynamics
-
Irving, Texas, United States, 75062
- Arm Dynamics
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Partial hand amputees with absence of index and/or middle fingers and presence of thumb. Additional finger loss is acceptable if all other criterion are met.
- Fluent in English
- Individuals aged 18 or greater
Exclusion Criteria:
- Significant cognitive deficits as determined upon clinical evaluation
- Significant neurological deficits as determined upon clinical evaluation
- Significant physical deficits of the residual limb impacting full participation in the study as determined upon clinical evaluation
- Uncontrolled pain or phantom pain impacting full participation in the study as determined upon occupational therapist evaluation
- Serious uncontrolled medical problems as judged by the project therapist.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: No Prosthesis
Baseline outcome measurements will be performed without a prosthesis
|
|
Experimental: Prosthesis
Outcome measurements will be performed after the subject has been fit with a prosthesis at 3 different points in time: immediately post-fitting, ~30 days post-fitting, and ~60 days post-fitting
|
Patient is fit with Point Digit partial hand prosthetic system
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Capacity Assessment of Prosthetic Performance for the Upper Limb (CAPPFUL)
Time Frame: Day 0: no prosthesis (pre-fitting)
|
Capacity Assessment of Prosthetic Performance for the Upper Limb (CAPPFUL) provides a comprehensive, performance based measure for upper limb prosthetic use with any upper-limb functional prosthesis at any amputation level through assessment of commonplace activities that take place in various planes of movement.
Scale Title: Overall Performance.
Scale Minimum: 0. Scale Maximum: 100.
Higher score indicates better outcome.
|
Day 0: no prosthesis (pre-fitting)
|
Disability of the Arm, Shoulder and Hand (DASH)
Time Frame: Day 0: no prosthesis (pre-fitting)
|
The Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire is a 30-item questionnaire that looks at the ability of a patient to perform certain upper extremity activities.
This questionnaire is a self-report questionnaire that patients can rate difficulty and interference with daily life on a 5 point Likert scale.
Scale Title: DASH Score.
Scale Minimum: 0. Scale Maximum: 100.
Higher score indicates worse outcome.
|
Day 0: no prosthesis (pre-fitting)
|
Southampton Hand Assessment Procedure (SHAP)
Time Frame: Day 0: no prosthesis (pre-fitting)
|
The Southampton Hand Assessment Procedure (SHAP) is a clinically validated hand function test.
Originally developed to assess the effectiveness of upper limb prostheses, the SHAP has now been applied to assessment of musculoskeletal and neurological conditions.
Scale Title: Index of Function.
Scale Minimum: 0. Scale Maximum: 100.
Higher score indicates better outcome.
|
Day 0: no prosthesis (pre-fitting)
|
EuroQol-5 Dimension (EQ-5D-5L)
Time Frame: Day 0: no prosthesis (pre-fitting)
|
Descriptive system for health-related quality of life states in adults, consisting of five dimensions (Mobility, Self-care, Usual activities, Pain & discomfort, Anxiety & depression), each of which has five severity levels that are described by statements appropriate to that dimension.
Scale Title: EQ-5D-5L Score.
Scale Minimum: 0. Scale Maximum: 100.
Higher score indicates better outcome.
|
Day 0: no prosthesis (pre-fitting)
|
Capacity Assessment of Prosthetic Performance for the Upper Limb (CAPPFUL)
Time Frame: Day 0: with prosthesis, immediately post-fitting
|
Capacity Assessment of Prosthetic Performance for the Upper Limb (CAPPFUL) provides a comprehensive, performance based measure for upper limb prosthetic use with any upper-limb functional prosthesis at any amputation level through assessment of commonplace activities that take place in various planes of movement.
Scale Title: Overall Performance.
Scale Minimum: 0. Scale Maximum: 100.
Higher score indicates better outcome.
|
Day 0: with prosthesis, immediately post-fitting
|
Disability of the Arm, Shoulder and Hand (DASH)
Time Frame: Day 0: with prosthesis, immediately post-fitting
|
The Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire is a 30-item questionnaire that looks at the ability of a patient to perform certain upper extremity activities.
This questionnaire is a self-report questionnaire that patients can rate difficulty and interference with daily life on a 5 point Likert scale.
Scale Title: DASH Score.
Scale Minimum: 0. Scale Maximum: 100.
Higher score indicates worse outcome.
|
Day 0: with prosthesis, immediately post-fitting
|
Southampton Hand Assessment Procedure (SHAP)
Time Frame: Day 0: with prosthesis, immediately post-fitting
|
The Southampton Hand Assessment Procedure (SHAP) is a clinically validated hand function test.
Originally developed to assess the effectiveness of upper limb prostheses, the SHAP has now been applied to assessment of musculoskeletal and neurological conditions.
Scale Title: Index of Function.
Scale Minimum: 0. Scale Maximum: 100.
Higher score indicates better outcome.
|
Day 0: with prosthesis, immediately post-fitting
|
EuroQol-5 Dimension (EQ-5D-5L)
Time Frame: Day 0: with prosthesis, immediately post-fitting
|
Descriptive system for health-related quality of life states in adults, consisting of five dimensions (Mobility, Self-care, Usual activities, Pain & discomfort, Anxiety & depression), each of which has five severity levels that are described by statements appropriate to that dimension.
Scale Title: EQ-5D-5L Score.
Scale Minimum: 0. Scale Maximum: 100.
Higher score indicates better outcome.
|
Day 0: with prosthesis, immediately post-fitting
|
Capacity Assessment of Prosthetic Performance for the Upper Limb (CAPPFUL)
Time Frame: ~Day 30: with prosthesis, 30 days post-fitting
|
Capacity Assessment of Prosthetic Performance for the Upper Limb (CAPPFUL) provides a comprehensive, performance based measure for upper limb prosthetic use with any upper-limb functional prosthesis at any amputation level through assessment of commonplace activities that take place in various planes of movement.
Scale Title: Overall Performance.
Scale Minimum: 0. Scale Maximum: 100.
Higher score indicates better outcome.
|
~Day 30: with prosthesis, 30 days post-fitting
|
Disability of the Arm, Shoulder and Hand (DASH)
Time Frame: ~Day 30: with prosthesis, 30 days post-fitting
|
The Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire is a 30-item questionnaire that looks at the ability of a patient to perform certain upper extremity activities.
This questionnaire is a self-report questionnaire that patients can rate difficulty and interference with daily life on a 5 point Likert scale.
Scale Title: DASH Score.
Scale Minimum: 0. Scale Maximum: 100.
Higher score indicates worse outcome.
|
~Day 30: with prosthesis, 30 days post-fitting
|
Southampton Hand Assessment Procedure (SHAP)
Time Frame: ~Day 30: with prosthesis, 30 days post-fitting
|
The Southampton Hand Assessment Procedure (SHAP) is a clinically validated hand function test.
Originally developed to assess the effectiveness of upper limb prostheses, the SHAP has now been applied to assessment of musculoskeletal and neurological conditions.
Scale Title: Index of Function.
Scale Minimum: 0. Scale Maximum: 100.
Higher score indicates better outcome.
|
~Day 30: with prosthesis, 30 days post-fitting
|
EuroQol-5 Dimension (EQ-5D-5L)
Time Frame: ~Day 30: with prosthesis, 30 days post-fitting
|
Descriptive system for health-related quality of life states in adults, consisting of five dimensions (Mobility, Self-care, Usual activities, Pain & discomfort, Anxiety & depression), each of which has five severity levels that are described by statements appropriate to that dimension.
Scale Title: EQ-5D-5L Score.
Scale Minimum: 0. Scale Maximum: 100.
Higher score indicates better outcome.
|
~Day 30: with prosthesis, 30 days post-fitting
|
Capacity Assessment of Prosthetic Performance for the Upper Limb (CAPPFUL)
Time Frame: ~Day 60: with prosthesis, 60 days post-fitting
|
Capacity Assessment of Prosthetic Performance for the Upper Limb (CAPPFUL) provides a comprehensive, performance based measure for upper limb prosthetic use with any upper-limb functional prosthesis at any amputation level through assessment of commonplace activities that take place in various planes of movement.
Scale Title: Overall Performance.
Scale Minimum: 0. Scale Maximum: 100.
Higher score indicates better outcome.
|
~Day 60: with prosthesis, 60 days post-fitting
|
Disability of the Arm, Shoulder and Hand (DASH)
Time Frame: ~Day 60: with prosthesis, 60 days post-fitting
|
The Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire is a 30-item questionnaire that looks at the ability of a patient to perform certain upper extremity activities.
This questionnaire is a self-report questionnaire that patients can rate difficulty and interference with daily life on a 5 point Likert scale.
Scale Title: DASH Score.
Scale Minimum: 0. Scale Maximum: 100.
Higher score indicates worse outcome.
|
~Day 60: with prosthesis, 60 days post-fitting
|
Southampton Hand Assessment Procedure (SHAP)
Time Frame: ~Day 60: with prosthesis, 60 days post-fitting
|
The Southampton Hand Assessment Procedure (SHAP) is a clinically validated hand function test.
Originally developed to assess the effectiveness of upper limb prostheses, the SHAP has now been applied to assessment of musculoskeletal and neurological conditions.
Scale Title: Index of Function.
Scale Minimum: 0. Scale Maximum: 100.
Higher score indicates better outcome.
|
~Day 60: with prosthesis, 60 days post-fitting
|
EuroQol-5 Dimension (EQ-5D-5L)
Time Frame: ~Day 60: with prosthesis, 60 days post-fitting
|
Descriptive system for health-related quality of life states in adults, consisting of five dimensions (Mobility, Self-care, Usual activities, Pain & discomfort, Anxiety & depression), each of which has five severity levels that are described by statements appropriate to that dimension.
Scale Title: EQ-5D-5L Score.
Scale Minimum: 0. Scale Maximum: 100.
Higher score indicates better outcome.
|
~Day 60: with prosthesis, 60 days post-fitting
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 18, 2020
Primary Completion (Actual)
December 31, 2022
Study Completion (Actual)
December 31, 2022
Study Registration Dates
First Submitted
November 16, 2020
First Submitted That Met QC Criteria
February 12, 2021
First Posted (Actual)
February 16, 2021
Study Record Updates
Last Update Posted (Estimated)
January 24, 2024
Last Update Submitted That Met QC Criteria
December 28, 2023
Last Verified
December 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 253924
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Amputation; Traumatic, Hand
-
Shirley Ryan AbilityLabEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsActive, not recruitingAmputation; Traumatic, Hand, and Wrist | Amputation; Traumatic, Hand, at Wrist LevelUnited States
-
Boninger, Michael, MDNational Institute of Neurological Disorders and Stroke (NINDS); Ripple Therapeutics...RecruitingAmputation | Amputation; Traumatic, HandUnited States
-
Liberating Technologies, Inc.Össur EhfCompletedAmputation | Prosthesis User | Amputation; Traumatic, Hand | Upper Limb Amputation at the Hand | Limb; Absence, Congenital, UpperUnited States
-
Point DesignsUniversity of Colorado, DenverCompletedAmputation; Traumatic, HandUnited States
-
Martin BerliBern University of Applied SciencesCompletedAmputation; Traumatic, HandSwitzerland
-
University of Texas Southwestern Medical CenterUniversity of Minnesota; Arizona State University; Defense Advanced Research... and other collaboratorsRecruitingAmputation; Traumatic, HandUnited States
-
Centre hospitalier de l'Université de Montréal...RecruitingAmputation; Traumatic, HandCanada
-
Centre hospitalier de l'Université de Montréal...RecruitingAmputation; Traumatic, HandCanada
-
Point DesignsUniversity of Colorado, Denver; Arm DynamicsCompletedAmputation; Traumatic, HandUnited States
-
Point DesignsUniversity of Colorado, DenverCompletedAmputation; Traumatic, HandUnited States
Clinical Trials on Point Digit
-
Point DesignsUniversity of Colorado, DenverCompletedAmputation; Traumatic, HandUnited States
-
Washington University School of MedicineRecruitingGynecologic CancerUnited States
-
Massachusetts General HospitalActive, not recruiting
-
Brain and Cognition Discovery FoundationTakeda; Cognition Kit; Ctrl Group, LtdCompleted
-
Rambam Health Care CampusCompletedWaterpipe SmokingIsrael
-
University Hospital Schleswig-HolsteinActive, not recruitingDigit Tip Wound | Split Skin Donor SiteGermany
-
University of Colorado, DenverColorado School of Public HealthRecruitingMultiple Sclerosis | Clinically Isolated Syndrome | Biomarkers | Magnetic Resonance Imaging | Radiologically Isolated SyndromeUnited States
-
University Hospital, CaenRecruitingDeep Vein ThrombosisFrance
-
Università degli Studi dell'InsubriaUnknownPostoperative Cognitive DysfunctionItaly
-
Johns Hopkins UniversityTerminatedChemotherapy-induced Peripheral Neuropathy (CIPN)United States